ImmunoACT ( @ActImmuno) Announces Dr Sattva Neelapu to join SAB. Findings of ZUMA trials by Dr Neelapu and team show efficacy of moving CAR-T therapy to earlier lines of therapy. Look forward working with him and build a world class SAB (@MDAndersonNews) faculty.mdanderson.org/profi…